you are
a patient
Présentation
The diseases treated by RITI®
Rheumatoid arthritis is the first disease targeted by the RITI® test
Biotherapies have revolutionized the treatment of rheumatoid arthritis.
The goal of prescribing a biotherapy is to
achieve remission of the disease
Background
Currently, there is no device available to assist doctors in choosing which biotherapy to prescribe in order to maximize the chances of remission.
Consequences
Some patients do not achieve remission according to the clinical values of the DAS28 :
- Persistent pain
Solution
mYXpression has developed RITI®, the first prescription assistance test to identify biotherapies adapted to your biology.
IVDMD with CE marking
A clinical trial is currently underway at 12 French research sites
Read more
Availability is currently planned for 2025
Other diseases will be treated
by RITI® in the future
Rheumatoid arthritis
Juvenile idiopathic arthritis
Crohn's disease
Hemorrhagic rectocolitis
Lupus
Psoriasis
Do you want to learn more about the availability of RITI® for other diseases?
contact us : info@myxpression.com
contact us : info@myxpression.com